Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New method reformulates pathogens into the body’s allies

02.09.2019

The Institute of Infectiology at the University of Münster in Germany has now signed with the American biomedical company “Innate Biologics” a Multi-Year Collaboration Agreement. The objective of the collaboration is to improve the possibilities for treating inflammatory skin diseases and autoimmune diseases – and, in the long term, to develop new medications.

Any agreement which entails benefits for both sides is called a win-win situation. This is precisely the result intended for the long-term cooperation and licensing agreement which the Institute of Infectiology at the University of Münster in Germany has now signed with an American biomedical company.


Team leader Dr Christian Rüter in the lab

FZ / E. Wibberg

The objective of the collaboration with Innate Biologics in Philadelphia, Pennsylvania, is to improve the possibilities for treating inflammatory skin diseases and autoimmune diseases – and, in the long term, to develop new medications.

The focus is on bacterial effectors – or, more precisely, on a recently discovered approach for immunotherapy. Work is being carried out on a protein family which has been researched by a team led by Dr Christian Rüter and the former Director of the Institute, Prof M. Alexander Schmidt.

Infectology involves investigating how exactly bacteria make their hosts – i.e. human beings – ill. If the immune system combats pathogens such as bacteria, it emits messenger substances which expand the blood vessels. The result is an inflammation. While this is a natural reaction to foreign bodies, bacteria find their own method of manipulating the immune system in humans.

“They now have a large repertoire of ways to deactivate the immune system, and this includes using so-called effectors and toxins,” explains Dr Rüter. Effectors are molecules which lead to a conversion of proteins and, as a result, a change in activity.

This gave the team of researchers an idea: if the effectors were adequately examined, and they could be separated from the actual pathogen causing the illness, they could be used for therapeutic purposes – to combat such inflammations. The Münster researchers are currently investigating an entire “family” of proteins – also known as CPE – which might offer a new possibility for treatment.

“The effectors of the bacteria have a range of very different functions. What we’re especially interested in is cell-penetrating characteristics – meaning that the cell membrane can be penetrated by the effectors,” says Dr Christian Rüter, explaining the method.

The so-called family of bacterial LPX-E3 ligases has been licenced. These are enzymes which act as a catalyst for the transfer of the ubiquitin protein to another protein – in other words, causing the two to bond together. The protein thus marked is bound and removed, so that inflammatory processes in the cell can be deactivated.

With aid of the family of proteins being researched in Münster, it is autoimmune diseases of the skin in particular which can be treated, such as psoriasis and atopic dermatitis. In the case of these diseases, the immune system harms the body which it is actually supposed to defend, and it destroys the body’s own tissue.

This is what the bacterial LPX-E3 ligases – which can penetrate into the cell without any aid and can act intracellularly – are designed to prevent. Instead of acting as a pathogen, the effectors – adapted over many years of evolution – can now be used to benefit the patient.

The aim of the agreement with Innate Biologics is clear: to develop and market new skin therapeuticss and cosmeceuticals. Peter Mondics, the managing director and co-founder of the company, is delighted that the cooperation agreement has been signed. “Our collaboration over the past year has led to a series of clinical findings which point to new types of effective skin biologics – or biopharmaceuticals.

These all have one thing in common: they down-regulate skin inflammatory signalling at the source, and, they are exceptionally patient-friendly.” This research into cosmeceuticals will make an enormous difference for people suffering from age-related skin diseases, and psoriasis says Mondics. Not many treatments are known for such cases, he adds. “This means that this cooperation between Innate Biologics and Münster University is an important USP in a very large market,” he says.

Innate Biologícs is an US company which specializes in the discovery, treatment and prevention of inflammation. The collaboration with Münster University began about a year ago, says Dr. Rüter. “The company approached us, and we didn’t hesitate to respond. And with the help of our faculty’s own Patent and Licensing Office, Clinic Invent, the agreement was ready for signing one year later,” he says.

The project, which began under her predecessor, is now being supported by the new Director of the Institute, Prof Petra Dersch. Other institutes within the Medical Faculty at Münster University are also involved in the cooperation – for example, Prof Karin Loser, Head of “Experimental Dermatology and Immunobiology of the Skin” at the University’s Department of Dermatology, is playing a key role in the project.

Wissenschaftliche Ansprechpartner:

Dr Christian Rüter
Institute of Infectiology, University of Münster
Mail: rueterc@uni-muenster.de
Phone: +49 251 83-56477

Dr. Thomas Bauer | idw - Informationsdienst Wissenschaft
Further information:
https://www.uni-muenster.de/

More articles from Life Sciences:

nachricht New tool improves beekeepers' overwintering odds and bottom line
19.09.2019 | US Department of Agriculture - Agricultural Research Service

nachricht Elusive compounds of greenhouse gas isolated by Warwick chemists
18.09.2019 | University of Warwick

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Stevens team closes in on 'holy grail' of room temperature quantum computing chips

Photons interact on chip-based system with unprecedented efficiency

To process information, photons must interact. However, these tiny packets of light want nothing to do with each other, each passing by without altering the...

Im Focus: Happy hour for time-resolved crystallography

Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Hamburg and the European Molecular Biology Laboratory (EMBL) outstation in the city have developed a new method to watch biomolecules at work. This method dramatically simplifies starting enzymatic reactions by mixing a cocktail of small amounts of liquids with protein crystals. Determination of the protein structures at different times after mixing can be assembled into a time-lapse sequence that shows the molecular foundations of biology.

The functions of biomolecules are determined by their motions and structural changes. Yet it is a formidable challenge to understand these dynamic motions.

Im Focus: Modular OLED light strips

At the International Symposium on Automotive Lighting 2019 (ISAL) in Darmstadt from September 23 to 25, 2019, the Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, a provider of research and development services in the field of organic electronics, will present OLED light strips of any length with additional functionalities for the first time at booth no. 37.

Almost everyone is familiar with light strips for interior design. LED strips are available by the metre in DIY stores around the corner and are just as often...

Im Focus: Tomorrow´s coolants of choice

Scientists assess the potential of magnetic-cooling materials

Later during this century, around 2060, a paradigm shift in global energy consumption is expected: we will spend more energy for cooling than for heating....

Im Focus: The working of a molecular string phone

Researchers from the Department of Atomically Resolved Dynamics of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg, the University of Potsdam (both in Germany) and the University of Toronto (Canada) have pieced together a detailed time-lapse movie revealing all the major steps during the catalytic cycle of an enzyme. Surprisingly, the communication between the protein units is accomplished via a water-network akin to a string telephone. This communication is aligned with a ‘breathing’ motion, that is the expansion and contraction of the protein.

This time-lapse sequence of structures reveals dynamic motions as a fundamental element in the molecular foundations of biology.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Society 5.0: putting humans at the heart of digitalisation

10.09.2019 | Event News

Interspeech 2019 conference: Alexa and Siri in Graz

04.09.2019 | Event News

AI for Laser Technology Conference: optimizing the use of lasers with artificial intelligence

29.08.2019 | Event News

 
Latest News

UMD-led study captures six galaxies undergoing sudden, dramatic transitions

19.09.2019 | Physics and Astronomy

Study points to new drug target in fight against cancer

19.09.2019 | Health and Medicine

New tool improves beekeepers' overwintering odds and bottom line

19.09.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>